These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35805743)

  • 41. Pre-exposure Prophylaxis Implementation in Family Planning Services Across the Southern United States: Findings from a Survey Among Staff, Providers and Administrators Working in Title X-Funded Clinics.
    Sales JM; Escoffery C; Hussen SA; Haddad LB; McCumber M; Kwiatkowski E; Filipowicz T; Sanchez M; Psioda MA; Sheth AN
    AIDS Behav; 2021 Jun; 25(6):1901-1912. PubMed ID: 33483899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reasons for PrEP Discontinuation After Navigation at Sexual Health Clinics: Interactions Among Systemic Barriers, Behavioral Relevance, and Medication Concerns.
    Unger ZD; Golub SA; Borges C; Edelstein ZR; Hedberg T; Myers J
    J Acquir Immune Defic Syndr; 2022 Jul; 90(3):316-324. PubMed ID: 35286280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Health Care Provider Perspectives on Pre-exposure Prophylaxis: A Qualitative Study.
    Przybyla S; LaValley S; St Vil N
    J Assoc Nurses AIDS Care; 2019; 30(6):630-638. PubMed ID: 30958406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Roadblocks to PrEP: What Medical Records Reveal About Access to HIV Pre-exposure Prophylaxis.
    Skolnik AA; Bokhour BG; Gifford AL; Wilson BM; Van Epps P
    J Gen Intern Med; 2020 Mar; 35(3):832-838. PubMed ID: 31705471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices.
    Sevelius JM; Deutsch MB; Grant R
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21105. PubMed ID: 27760683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multilevel Factors Shaping Awareness of and Attitudes Toward Pre-exposure Prophylaxis for HIV Prevention among Criminal Justice-Involved Women.
    Dauria EF; Levine A; Hill SV; Tolou-Shams M; Christopoulos K
    Arch Sex Behav; 2021 May; 50(4):1743-1754. PubMed ID: 33236275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP.
    Blumenthal J; Jain S; Krakower D; Sun X; Young J; Mayer K; Haubrich R;
    AIDS Behav; 2015 May; 19(5):802-10. PubMed ID: 25616837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tennessee Pharmacists' Opinions on Barriers and Facilitators to Initiate PrEP: A Qualitative Study.
    Cernasev A; Walker C; Kerr C; Barenie RE; Armstrong D; Golden J
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
    PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Missed Opportunities to Prescribe HIV Pre-Exposure Prophylaxis by Primary Care Providers in Saint Louis, Missouri.
    Patel RR; Chan PA; Harrison LC; Mayer KH; Nunn A; Mena LA; Powderly WG
    LGBT Health; 2018; 5(4):250-256. PubMed ID: 29688800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determinants of Implementation for HIV Pre-exposure Prophylaxis Based on an Updated Consolidated Framework for Implementation Research: A Systematic Review.
    Li DH; Benbow N; Keiser B; Mongrella M; Ortiz K; Villamar J; Gallo C; Deskins JS; Xavier Hall CD; Miller C; Mustanski B; Smith JD
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S235-S246. PubMed ID: 35703776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians.
    Blackstock OJ; Moore BA; Berkenblit GV; Calabrese SK; Cunningham CO; Fiellin DA; Patel VV; Phillips KA; Tetrault JM; Shah M; Edelman EJ
    J Gen Intern Med; 2017 Jan; 32(1):62-70. PubMed ID: 27778215
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pre-exposure Prophylaxis Knowledge and Use Among Men Who Have Sex With Men in a Small Metropolitan Region of the Southeastern United States.
    Griffin JA; Eldridge-Smith ED; Yohannan J; Stepleman LM
    J Assoc Nurses AIDS Care; 2020; 31(1):80-91. PubMed ID: 31433361
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrating HIV Pre-Exposure Prophylaxis into Family Planning Care: A RE-AIM Framework Evaluation.
    Brant AR; Dhillon P; Hull S; Coleman M; Ye PP; Lotke PS; Folan J; Scott RK
    AIDS Patient Care STDS; 2020 Jun; 34(6):259-266. PubMed ID: 32484743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differing Experiences with Pre-Exposure Prophylaxis in Boston Among Lesbian, Gay, Bisexual, and Transgender Specialists and Generalists in Primary Care: Implications for Scale-Up.
    Krakower DS; Ware NC; Maloney KM; Wilson IB; Wong JB; Mayer KH
    AIDS Patient Care STDS; 2017 Jul; 31(7):297-304. PubMed ID: 28574774
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Impact of HIV Pre-Exposure Prophylaxis (PrEP) Counseling on PrEP Knowledge and Attitudes Among Women Seeking Family Planning Care.
    O'Connell HR; Criniti SM
    J Womens Health (Larchmt); 2021 Jan; 30(1):121-130. PubMed ID: 32493156
    [No Abstract]   [Full Text] [Related]  

  • 57. Perspectives on the utility and interest in a point-of-care urine tenofovir test for adherence to HIV pre-exposure prophylaxis and antiretroviral therapy: an exploratory qualitative assessment among U.S. clients and providers.
    Bardon AR; Simoni JM; Layman LM; Stekler JD; Drain PK
    AIDS Res Ther; 2020 Aug; 17(1):50. PubMed ID: 32762713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Considering Stigma in the Provision of HIV Pre-Exposure Prophylaxis: Reflections from Current Prescribers.
    Calabrese SK; Tekeste M; Mayer KH; Magnus M; Krakower DS; Kershaw TS; Eldahan AI; Gaston Hawkins LA; Underhill K; Hansen NB; Betancourt JR; Dovidio JF
    AIDS Patient Care STDS; 2019 Feb; 33(2):79-88. PubMed ID: 30715918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlates of PrEP Uptake Among Young Sexual Minority Men and Transgender Women in New York City: The Need to Reframe "Risk" Messaging and Normalize Preventative Health.
    Jaiswal J; LoSchiavo C; Meanley S; Hascher K; Cox AB; Dunlap KB; Singer SN; Halkitis PN
    AIDS Behav; 2021 Oct; 25(10):3057-3073. PubMed ID: 33830327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex with Men (MSM): A Scoping Review on PrEP Service Delivery and Programming.
    Hillis A; Germain J; Hope V; McVeigh J; Van Hout MC
    AIDS Behav; 2020 Nov; 24(11):3056-3070. PubMed ID: 32274670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.